BR112023025528A2 - Peptídeos grampeados e métodos destes - Google Patents
Peptídeos grampeados e métodos destesInfo
- Publication number
- BR112023025528A2 BR112023025528A2 BR112023025528A BR112023025528A BR112023025528A2 BR 112023025528 A2 BR112023025528 A2 BR 112023025528A2 BR 112023025528 A BR112023025528 A BR 112023025528A BR 112023025528 A BR112023025528 A BR 112023025528A BR 112023025528 A2 BR112023025528 A2 BR 112023025528A2
- Authority
- BR
- Brazil
- Prior art keywords
- present disclosure
- disclosure provides
- catenin
- beta
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
- C07K1/1072—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups
- C07K1/1077—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides by covalent attachment of residues or functional groups by covalent attachment of residues other than amino acids or peptide residues, e.g. sugars, polyols, fatty acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/04—Linear peptides containing only normal peptide links
- C07K7/08—Linear peptides containing only normal peptide links having 12 to 20 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163208487P | 2021-06-08 | 2021-06-08 | |
| US202163224834P | 2021-07-22 | 2021-07-22 | |
| US202263303952P | 2022-01-27 | 2022-01-27 | |
| PCT/US2022/032738 WO2022261257A1 (en) | 2021-06-08 | 2022-06-08 | Stapled peptides and methods thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR112023025528A2 true BR112023025528A2 (pt) | 2024-02-27 |
Family
ID=84425507
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR112023025528A BR112023025528A2 (pt) | 2021-06-08 | 2022-06-08 | Peptídeos grampeados e métodos destes |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20240360179A1 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4355350A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024522368A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20240031957A (cg-RX-API-DMAC10.html) |
| BR (1) | BR112023025528A2 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3218824A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL308790A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023014679A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022261257A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR112020004555A2 (pt) | 2017-09-07 | 2020-09-24 | Fog Pharmaceuticals, Inc. | agentes que modulam funções de beta-catenina e métodos dos mesmos |
| AU2019326423A1 (en) | 2018-08-20 | 2021-04-08 | Fog Pharmaceuticals, Inc. | Collections of peptides, peptide agents, and methods of use thereof |
| US20260207704A1 (en) * | 2022-12-15 | 2026-07-23 | Parabilis Medicines, Inc. | Stapled peptides and methods thereof |
| WO2024130217A1 (en) * | 2022-12-15 | 2024-06-20 | Fog Pharmaceuticals, Inc. | Stapled peptides and methods thereof |
| WO2024130224A2 (en) * | 2022-12-16 | 2024-06-20 | Purdue Research Foundation | Stapled peptides for sensitization of cancer to treatment |
| JP2026520144A (ja) * | 2023-06-06 | 2026-06-22 | パラビリス メディシンズ, インコーポレイテッド | ステープルペプチドおよびその方法 |
| WO2025265097A1 (en) * | 2024-06-20 | 2025-12-26 | Parabilis Medicines, Inc. | Stapled peptides and methods thereof |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2508531B1 (en) * | 2007-03-28 | 2016-10-19 | President and Fellows of Harvard College | Stitched polypeptides |
| EP3549951A3 (en) * | 2008-12-09 | 2019-11-20 | Dana Farber Cancer Institute, Inc. | Methods and compositions for specific modulation of mcl-1 |
| WO2012040459A2 (en) * | 2010-09-22 | 2012-03-29 | President And Fellows Of Harvard College | Beta-catenin targeting peptides and uses thereof |
| EP3782638A1 (en) * | 2013-03-13 | 2021-02-24 | President and Fellows of Harvard College | Stapled and stitched polypeptides and uses thereof |
| WO2016085280A1 (ko) * | 2014-11-28 | 2016-06-02 | 서울대학교산학협력단 | 세포 투과성 스테이플 펩타이드, 이의 제조방법 및 그 용도 |
| US10011631B2 (en) * | 2015-12-01 | 2018-07-03 | The University Of Hong Kong | Stapled helical peptides and methods of synthesis |
| BR112020004555A2 (pt) * | 2017-09-07 | 2020-09-24 | Fog Pharmaceuticals, Inc. | agentes que modulam funções de beta-catenina e métodos dos mesmos |
| CN111447941B (zh) * | 2017-10-27 | 2023-10-31 | 俄亥俄州国家创新基金会 | 用于细胞内递送装订肽的多肽缀合物 |
| AU2019326423A1 (en) * | 2018-08-20 | 2021-04-08 | Fog Pharmaceuticals, Inc. | Collections of peptides, peptide agents, and methods of use thereof |
| CA3186681A1 (en) * | 2020-07-22 | 2022-01-27 | Brian Halbert WHITE | Stapled peptides and methods thereof |
-
2022
- 2022-06-08 BR BR112023025528A patent/BR112023025528A2/pt unknown
- 2022-06-08 EP EP22820994.6A patent/EP4355350A4/en active Pending
- 2022-06-08 CA CA3218824A patent/CA3218824A1/en active Pending
- 2022-06-08 MX MX2023014679A patent/MX2023014679A/es unknown
- 2022-06-08 WO PCT/US2022/032738 patent/WO2022261257A1/en not_active Ceased
- 2022-06-08 JP JP2023575560A patent/JP2024522368A/ja active Pending
- 2022-06-08 KR KR1020237042998A patent/KR20240031957A/ko active Pending
- 2022-06-08 US US18/568,212 patent/US20240360179A1/en active Pending
- 2022-06-08 IL IL308790A patent/IL308790A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL308790A (en) | 2024-01-01 |
| JP2024522368A (ja) | 2024-06-18 |
| US20240360179A1 (en) | 2024-10-31 |
| EP4355350A4 (en) | 2025-10-01 |
| WO2022261257A1 (en) | 2022-12-15 |
| EP4355350A1 (en) | 2024-04-24 |
| CA3218824A1 (en) | 2022-12-15 |
| KR20240031957A (ko) | 2024-03-08 |
| MX2023014679A (es) | 2024-01-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023000947A (es) | Peptidos grapados y metodos para su obtencion. | |
| MX2023014679A (es) | Peptidos grapados y metodos para su obtencion. | |
| BR112022007627A2 (pt) | Compostos moduladores do glp-1r | |
| BR112022017930A2 (pt) | Anticorpos anticoronavírus e métodos de uso | |
| BR112023021978A2 (pt) | Compostos de carbóxi-benzimidazol moduladores de glp-1r | |
| BR112023021561A2 (pt) | Compostos de carbóxi-benzimidazol moduladores de glp-1r | |
| MX2022004343A (es) | Anticuerpos modificados genéticamente como degradadores moleculares a través de receptores celulares. | |
| BR112022021884A2 (pt) | Proteínas que se ligam a nkg2d, cd16 e clec12a | |
| WO2019051327A3 (en) | BETA CATENIN FUNCTIONALIZATION AGENTS AND ASSOCIATED METHODS | |
| EA202190708A1 (ru) | Модуляторы экспрессии pnpla3 | |
| PE20141561A1 (es) | Anticuerpos anti-lrp5 y metodos de uso | |
| CO2018000104A2 (es) | Moléculas de anticuerpo que se unen a cd22 | |
| UA130422C2 (uk) | Варіант та ізоформа антитіла зі зниженою біологічною активністю | |
| BR0209792A (pt) | Anticorpos para vla-1 | |
| BR112021021645A2 (pt) | Anticorpos anti-hvem e uso dos mesmos. | |
| BRPI0906478B8 (pt) | anticorpo anti-nr10, seu uso e composição farmacêutica que o compreende | |
| PE20140673A1 (es) | Nuevos moduladores y metodos para su uso | |
| BRPI0517837A (pt) | variantes fc com ligação alterada a fcrn | |
| GT200900264A (es) | Moléculas y métodos para modular la pro-proteina | |
| MX2012009088A (es) | Anticuerpos que se enlazan a lisil oxidasa-tipo2 (loxl2) y metodos de uso para los mismos. | |
| ZA202208280B (en) | Antibody molecules to c5ar1 and uses thereof | |
| CO2023015915A2 (es) | Anticuerpos anti-ccr8 | |
| EA200901067A1 (ru) | Использование семафорина 6а в качестве промотора миелинизации и дифференцировки олигодендроцитов | |
| AU2021269176A8 (en) | Single domain antibodies binding to SARS-CoV-2 spike protein | |
| BR112019003816A2 (pt) | composição de tratamento de enxágue dos cabelos, método para tratamento de cabelos quimicamente danificados e uso de uma composição |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B25D | Requested change of name of applicant approved |
Owner name: PARABILIS MEDICINES, INC. (US) |